Andrei Gartel
Affiliations: | Biochemistry and Molecular Genetics | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Molecular Biology, BiochemistryGoogle:
"Andrei Gartel"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Raghuwanshi S, Gartel AL. (2023) Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments. Biochimica Et Biophysica Acta. Reviews On Cancer. 1878: 189015 |
| Chesnokov MS, Borhani S, Halasi M, et al. (2021) FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML. Frontiers in Oncology. 11: 696532 |
| Chesnokov MS, Halasi M, Borhani S, et al. (2021) Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells. Cell Death & Disease. 12: 704 |
| Borhani S, Gartel AL. (2020) FOXM1: a potential therapeutic target in human solid cancers. Expert Opinion On Therapeutic Targets. 1-13 |
| Khan I, Halasi M, Patel A, et al. (2018) FOXM1 contributes to treatment failure in acute myeloid leukemia. Jci Insight. 3 |
| Halasi M, Hitchinson B, Shah BN, et al. (2018) Honokiol is a FOXM1 antagonist. Cell Death & Disease. 9: 84 |
| Gartel AL. (2017) FOXM1 in Cancer: Interactions and Vulnerabilities. Cancer Research |
| Khan I, Halasi M, Zia MF, et al. (2016) Nuclear FOXM1 drives chemoresistance in AML. Leukemia |
| Halasi M, Váraljai R, Benevolenskaya E, et al. (2016) A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS. The Journal of Biological Chemistry. 291: 142-8 |
| Khan I, Gartel A, Halasi M. (2016) Inhibition of FOXM1 By Ixazomib Confers Chemosensitivity in NPM1-Wild Type Acute Myeloid Leukemia Blood. 128: 1577-1577 |